eIF4A emerges as a potential Achilles’ heel for triple-negative breast cancer
Targeting eIF4A to interfere with the synthesis of proteins the cancer needs to grow is producing promising results.
Read MoreTargeting eIF4A to interfere with the synthesis of proteins the cancer needs to grow is producing promising results.
Read MoreThis study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.
Read MoreResearchers identified a tumor protein signature that predicts chemotherapy sensitivity and favorable clinical outcomes.
Read MoreThe findings help predict tumor response so that only effective treatments are given.
Read MoreResearchers identified a combination therapy for triple-negative breast cancer that results in durable tumor regression in an animal model.
Read MoreMAPK4 seems to be involved in promoting triple-negative breast cancer growth and its resistance to certain therapies.
Read MoreEndogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.
Read MoreUnraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And
Read MoreWhen it comes to finding new drugs to treat breast cancer, some scientists are taking an approach that could expedite the discovery of new treatments.
Read MoreStephanie D. Miller knew breast cancer ran in her family, and with her dense breast tissue, she was religious about getting her annual mammogram. She
Read More